Cargando…
HMQ‐T‐B10 induces human liver cell apoptosis by competitively targeting EphrinB2 and regulating its pathway
Hepatocellular carcinoma (HCC) is a highly prevalent cancer worldwide and it is necessary to discover and develop novel preventive strategies and therapeutic approaches for HCC. Herein, we report that EphrinB2 expression is correlated with liver cancer progression. Moreover, by using phosphorylated...
Autores principales: | Dai, Bingling, Shi, Xianpeng, Ma, Nan, Ma, Weina, Zhang, Yanmin, Yang, Tianfeng, Zhang, Jie, He, Langchong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6201340/ https://www.ncbi.nlm.nih.gov/pubmed/30589500 http://dx.doi.org/10.1111/jcmm.13729 |
Ejemplares similares
-
HMQ‐T‐F2 exert antitumour effects by upregulation of Axin in human cervical HeLa cells
por: Dai, Bingling, et al.
Publicado: (2018) -
Vandetanib drives growth arrest and promotes sensitivity to imatinib in chronic myeloid leukemia by targeting ephrin type‐B receptor 4
por: Ma, Weina, et al.
Publicado: (2022) -
EphB/ephrinB Signaling in Cell Adhesion and Migration
por: Park, Inji, et al.
Publicado: (2015) -
EphB4/EphrinB2 therapeutics in Rhabdomyosarcoma
por: Randolph, Matthew E., et al.
Publicado: (2017) -
EphrinB2 overexpression enhances osteogenic differentiation of dental pulp stem cells partially through ephrinB2-mediated reverse signaling
por: Wang, Wen, et al.
Publicado: (2020)